Symbicort and health economics in a real life evaluation - SHARE - A randomised, open-label, parallel-group, multicentre study to assess the asthma-related health-care costs, in ordinary clinical practice during 12 months.

Trial Profile

Symbicort and health economics in a real life evaluation - SHARE - A randomised, open-label, parallel-group, multicentre study to assess the asthma-related health-care costs, in ordinary clinical practice during 12 months.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Budesonide; Budesonide/formoterol; Formoterol; Terbutaline
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms SHARE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Jan 2011 Last checked against ClinicalTrials.gov record.
    • 08 Oct 2008 Results presented at ERS in Oct 2008.
    • 01 Oct 2008 Results published in Respiratory Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top